PROM1 and breast cancer: (2011) involving multiple breast cancer cell lines (MCF‐7, MDA MB231, and T47D) and primary tumors also revealed that cells that escaped from doxorubicin‐induced senescence exhibit stem cell characteristics with increased levels of the stem cell markers CD133 and OCT4 [46].